Jeff Lynn Myers - Dec 27, 2023 Form 4 Insider Report for Beyond Air, Inc. (XAIR)

Role: Chief Medical Officer
Signature: /s/ Adam T. Newman, as attorney-in-fact
Stock symbol: XAIR
Transactions as of: Dec 27, 2023
Transactions value $: -$7,579
Form type: 4
Date filed: 12/29/2023, 04:15 PM
Previous filing: Mar 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XAIR	Common Stock	Sale	-$7.58K	-3.42K	-6.85%	$2.21	46.6K	Dec 27, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares of common stock of Beyond Air, Inc. sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously granted restricted stock units.
F2	This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.15 to $2.34, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Content

The sales reported on this Form 4 represent shares of common stock of Beyond Air, Inc. sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously granted restricted stock units.

This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.15 to $2.34, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.